Fluorine-labeled Dasatinib Nanoformulations as Targeted Molecular Imaging Probes in a PDGFB-driven Murine Glioblastoma Model

Dasatinib, a new-generation Src and platelet-derived growth factor receptor (PDGFR) inhibitor, is currently under evaluation in high-grade glioma clinical trials. To achieve optimum physicochemical and/or biologic properties, alternative drug delivery vehicles may be needed. We used a novel fluorina...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Benezra, Miriam, Hambardzumyan, Dolores, Penate-Medina, Oula, Veach, Darren R, Pillarsetty, Nagavarakishore, Smith-Jones, Peter, Phillips, Evan, Ozawa, Tatsuya, Zanzonico, Pat B, Longo, Valerie, Holland, Eric C, Larson, Steven M, Bradbury, Michelle S
Formato: Artigo
Idioma:Inglês
Publicado em: Neoplasia Press Inc. 2012
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3540940/
https://ncbi.nlm.nih.gov/pubmed/23308046
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados